Koji Mukasa
Overview
Explore the profile of Koji Mukasa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
496
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Suzuki N, Yoshimura Noh J, Kameda T, Yoshihara A, Ohye H, Suzuki M, et al.
Clin Ophthalmol
. 2018 May;
12:739-746.
PMID: 29719374
Background: Euthyroid Graves' disease (EGD) is a rare condition defined as the presence of thyroid-associated ophthalmopathy (TAO) in patients with normal thyroid function. Due to the rarity of this disease,...
2.
Yoshihara A, Yoshimura Noh J, Mukasa K, Watanabe N, Iwaku K, Ohye H, et al.
Endocr J
. 2016 Sep;
63(12):1113-1122.
PMID: 27600197
Overt hyperthyroidism is associated with reduced bone density. The extent of restoration of reduced bone density caused by hyperthyroidism in postmenopausal Graves' disease (GD) patients has not fully been investigated....
3.
Mukasa K, Yoshimura Noh J, Kouzaki A, Ohye H, Kunii Y, Watanabe N, et al.
Endocr J
. 2015 Nov;
63(2):151-7.
PMID: 26581710
TSH receptor antibody (TRAb) titer has been reported to be correlated with Graves' ophthalmopathy (GO). However, the correlation between GO activity and TRAb titer assessed with a third-generation assay has...
4.
Kunii Y, Uruno T, Mukasa K, Sekiya K, Iwaku K, Suzuki A, et al.
Endocr J
. 2015 Nov;
63(1):21-7.
PMID: 26560237
In the event of a nuclear power plant accident, prophylactic administration of potassium iodide (KI) is recommended to prevent thyroid damage due to uptake of radioiodine. To assess the inhibitory...
5.
Yoshihara A, Yoshimura Noh J, Watanabe N, Mukasa K, Ohye H, Suzuki M, et al.
Thyroid
. 2015 Jul;
25(10):1155-61.
PMID: 26222916
Background: To control hyperthyroidism due to Graves' disease, antithyroid drugs should be administered. Several studies have shown that exposure to methimazole (MMI) during the first trimester of pregnancy increases the...
6.
Watanabe N, Yoshimura Noh J, Kozaki A, Iwaku K, Sekiya K, Kosuga Y, et al.
J Clin Endocrinol Metab
. 2015 May;
100(7):2700-8.
PMID: 25965082
Context: Exacerbation of Graves' orbitopathy (GO) after radioiodine (RAI) therapy has been examined in some populations but has not been fully described in Japanese populations. Objective: The purpose of this...
7.
Yoshihara A, Yoshimura Noh J, Mukasa K, Suzuki M, Ohye H, Matsumoto M, et al.
Endocr J
. 2015 Mar;
62(6):557-60.
PMID: 25819223
Gestational transient thyrotoxicosis (GTT) is defined as transient thyrotoxicosis caused by the stimulating effect of human chorionic gonadotropin (hCG) during pregnancy. We attempted to identify the serum hCG level that...
8.
Sato S, Yoshimura Noh J, Sato S, Suzuki M, Yasuda S, Matsumoto M, et al.
Thyroid
. 2014 Sep;
25(1):43-50.
PMID: 25178068
Background: Methimazole (MMI) is usually used at an initial dose of 30 mg/day for severe Graves' disease (GD) hyperthyroidism, but adverse effects are more frequent at this dose than at...
9.
Iwaku K, Yoshimura Noh J, Sasaki E, Suzuki N, Kameda T, Kobayashi S, et al.
Endocr J
. 2014 Jul;
61(9):875-81.
PMID: 25008050
Following the accident at the Fukushima Daiichi Nuclear Power Station which occurred on March 11, 2011 due to the Eastern Japan Great Earthquake (the Accident), there have been concerns over...
10.
Yoshihara A, Yoshimura Noh J, Watanabe N, Iwaku K, Kobayashi S, Suzuki M, et al.
Clin Nucl Med
. 2014 Feb;
39(4):326-9.
PMID: 24566408
Purpose Of The Report: The incidence of postpartum thyrotoxicosis (PT) in Graves disease (GD) patients treated with antithyroid drugs (ATDs) is higher than in the general population, but the incidence...